Fig. 2: Estimates of inverse probability of censoring-weighted cumulative risk functions of SARS-CoV-2 infection by the protocol for Pfizer-BioNTech (panel a) and Moderna recipients (panel b). | Nature Communications

Fig. 2: Estimates of inverse probability of censoring-weighted cumulative risk functions of SARS-CoV-2 infection by the protocol for Pfizer-BioNTech (panel a) and Moderna recipients (panel b).

From: Comparative effectiveness of alternative intervals between first and second doses of the mRNA COVID-19 vaccines

Fig. 2

Data are presented as point estimates (solid lines) and 95% confidence intervals (shaded areas represent) using a nonparametric bootstrap based on 200 resamples. Blue lines are estimates under the recommended protocol. Yellow lines are estimates under the late-but-allowable protocol. Pink lines are estimates under the late protocol.

Back to article page